Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study

M Glabbeke; Jaap Verweij; PG Casali; A le Cesne; P Hohenberger; I Ray-Coquard; M Schlemmer; AT van Oosterom; DS Goldstein; R Sciot; PCW Hogendoorn; M Brown; R Bertulli; IR Judson

Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study

M Glabbeke, Jaap Verweij, PG Casali, A le Cesne, P Hohenberger, I Ray-Coquard, M Schlemmer, AT van Oosterom, DS Goldstein, R Sciot, PCW Hogendoorn, M Brown, R Bertulli, IR Judson

Research output: Contribution to journal › Article › Academic › peer-review

257 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	5795-5804
Number of pages	10
Journal	Journal of Clinical Oncology
Volume	23
Publication status	Published - 2005
Externally published	Yes

Cite this

Glabbeke, M., Verweij, J., Casali, PG., le Cesne, A., Hohenberger, P., Ray-Coquard, I., Schlemmer, M., van Oosterom, AT., Goldstein, DS., Sciot, R., Hogendoorn, PCW., Brown, M., Bertulli, R., & Judson, IR. (2005). Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study. Journal of Clinical Oncology, 23, 5795-5804.

@article{498016e817cf43cdb00ecbb88bcd28fa,

title = "Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study",

author = "M Glabbeke and Jaap Verweij and PG Casali and {le Cesne}, A and P Hohenberger and I Ray-Coquard and M Schlemmer and {van Oosterom}, AT and DS Goldstein and R Sciot and PCW Hogendoorn and M Brown and R Bertulli and IR Judson",

year = "2005",

language = "Undefined/Unknown",

volume = "23",

pages = "5795--5804",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

Glabbeke, M, Verweij, J, Casali, PG, le Cesne, A, Hohenberger, P, Ray-Coquard, I, Schlemmer, M, van Oosterom, AT, Goldstein, DS, Sciot, R, Hogendoorn, PCW, Brown, M, Bertulli, R & Judson, IR 2005, 'Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study', Journal of Clinical Oncology, vol. 23, pp. 5795-5804.

TY - JOUR

T1 - Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study

AU - Glabbeke, M

AU - Verweij, Jaap

AU - Casali, PG

AU - le Cesne, A

AU - Hohenberger, P

AU - Ray-Coquard, I

AU - Schlemmer, M

AU - van Oosterom, AT

AU - Goldstein, DS

AU - Sciot, R

AU - Hogendoorn, PCW

AU - Brown, M

AU - Bertulli, R

AU - Judson, IR

PY - 2005

Y1 - 2005

M3 - Article

SN - 0732-183X

VL - 23

SP - 5795

EP - 5804

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -